The Evolving Landscape of Immunotherapy in Uterine Cancer

Endometrial cancer affects the uterus and is becoming increasingly common and deadly. Although surgery and adjuvant pelvic radiotherapy can ...

The Evolving Landscape of Immunotherapy in Uterine Cancer - MDPI

Current data suggest that active and/or passive immunotherapy may be promising for the treatment of endometrial cancer.

[PDF] The Evolving Landscape of Immunotherapy in Uterine Cancer

Current data suggest that active and/or passive immunotherapy may be promising for the treatment of endometrial cancer. Endometrial cancer affects the ...

Evolving Treatment Landscape in Endometrial Cancer

In particular, immunotherapy has improved clinical outcomes, both as monotherapy and in combination with other agents, in patients with ...

The Evolving Landscape of Immunotherapy in Uterine Cancer

To address this unmet clinical need, innovative treatment strategies are needed, and a growing focus on the immunomodulation of the tumor microenvironment has ...

The future of immunotherapy evolving in the management of uterine ...

More from Ritu Salani ; 1:09. Broadening horizons in immuno-oncology: insights from PRIMO 2024 ; 0:45. Advancing uterine cancer management ; 0:35.

Evolving Role of Immunotherapy in Endometrial Cancer

0:10 | Immunotherapy definitely has impacted endometrial cancer management. In fact, at the Society of Gynecologic Oncology meeting that was in ...

The Evolving Landscape of Immunotherapy in Uterine Cancer - OUCI

Endometrial cancer affects the uterus and is becoming increasingly common and deadly. Although surgery and adjuvant pelvic radiotherapy can often cure the ...

A rapidly evolving landscape: immune checkpoint inhibitors in ...

The majority of patients with endometrial cancer have tumors that are MMR proficient (MMRp) and microsatellite stable (MSS), although the less ...

Expanding Horizons in Endometrial Cancer Treatment - OncLive

Delve into the exciting developments in endometrial cancer treatment, including HER2 antibody drug conjugates, checkpoint inhibitors, ...

Adding immunotherapy to first-line treatment of advanced and ...

The incorporation of immunotherapy into the initial treatment for advanced and metastatic endometrial cancer brings about a substantial improvement in oncologic ...

Immunotherapy in endometrial cancer - an evolving therapeutic ...

What is known about the microenvironment in endometrial cancer and what has been learned from preliminary immunotherapy trials that enrolled patients are ...

Update on the Evolving Landscape for Endometrial Cancer ...

help guide treatment decisions and the role of immunotherapy in treating endometrial cancer. ... • To explore the evolution of diagnosis ...

Adding immunotherapy to first-line treatment of advanced and ...

Immunotherapy has transformed the endometrial cancer treatment landscape, particularly for those exhibiting mismatch repair deficiency [MMRd ...

Evolving Treatment Landscape in Endometrial Cancer

Recently, clinical trials have shown promising results for immunotherapy and targeted therapies in patients with advanced or metastatic ...

The Evolving Landscape in Molecular-Driven Investigational ...

The Evolving Landscape in Molecular-Driven Investigational Therapies for Advanced Endometrial Cancer. 793 views · 10 months ago ...more ...

Immunotherapy Advances the Treatment Landscape of Endometrial ...

Shannon N. Westin, MD, MPH, FACOG, discusses the evolving role of immunotherapy as treatment of patients with endometrial cancer.

Evolving treatment landscape of advanced endometrial cancer

First-line systemic therapy of advanced, previously system-therapeutically untreated EC is a combination chemotherapy with carboplatin and ...

Immunotherapy treatment landscape for patients with endometrial ...

Traditionally, systemic treatment has included combination platinum- and taxane-based chemotherapy. More recently, the identification of molecular subtypes has ...

The evolving landscape of immunotherapy against cancer

Adoptive immunotherapy consists instead in the direct administration of a population of tumor specific antigens T-Lymphocytes, which have been ...